Patients with paradoxical low-flow, low-gradient aortic stenosis gain the least benefit from TAVI among all hemodynamic subtypes.
Miriam PulsBo Eric BeuthnerRodi TopciChristoph Friedemann JacobKristin Elisabeth SteinhausNiels PaulTim BeißbarthKarl ToischerClaudius JacobshagenGerd HasenfußPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2024)
PLF-LG patients exhibit the highest mortality (particularly CV and SCD), the poorest symptomatic benefit and the least reverse cardiac remodelling after TAVI among all subtypes. Thus, this cohort seems to gain the least benefit.
Keyphrases
- aortic stenosis
- ejection fraction
- transcatheter aortic valve implantation
- transcatheter aortic valve replacement
- aortic valve
- aortic valve replacement
- left ventricular
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- type diabetes
- peritoneal dialysis
- heart failure
- cardiovascular disease
- risk factors
- patient reported outcomes